by GOAI

由GOAI生成

Share To

分享到

Third Rock Ventures has led a $165 million funding round for a new biotechnology company focused on schizophrenia treatments, founded by Steve Paul. The investment supports the latest spinout from Paul, who is known for his work in neuroscience and drug development. This financing round aims to advance research and development efforts targeting innovative solutions for schizophrenia, a complex mental health condition..

Third Rock Ventures 领投了一家专注于精神分裂症治疗的新型生物技术公司，该公司由史蒂夫·保罗创立，此轮融资金额达 1.65 亿美元。这项投资支持了保罗最新的创业项目，他以其在神经科学和药物开发领域的工作而闻名。本轮融资旨在推动针对精神分裂症这一复杂心理健康问题的创新解决方案的研究与开发工作。

In addition to Third Rock’s backing of Paul’s venture, other significant funding rounds were announced in the biotech sector. Ambros and Atavistik have secured substantial investments to support their respective projects, while MBX has launched a fund dedicated to addressing chronic diseases. These developments highlight ongoing financial activity within the industry as companies seek resources to tackle pressing medical challenges..

除了Third Rock对Paul的项目提供支持外，生物技术领域还宣布了其他几轮融资。Ambros和Atavistik已获得重大投资以支持各自的项目，而MBX则推出了一只专注于应对慢性疾病的基金。这些进展突显了行业内持续的金融活动，因为各家公司正在寻求资源以应对紧迫的医疗挑战。

Newsflash | Powered by GeneOnline AI

新闻快讯 | 由GeneOnline AI提供支持

Source: GO-AI-ne1

来源：GO-AI-ne1

For any suggestion and feedback, please contact us.

如果有任何建议和反馈，请联系我们。

Date: December 18, 2025

日期：2025年12月18日

Related posts:

相关文章：

Cullinan Oncology Secures $712 Million Deal with Genrix for BCMA and CD19 Bispecific T Cell Engagers

Cullinan Oncology与Genrix达成7.12亿美元的BCMA和CD19双特异性T细胞接合器协议

Survey of 90 Biopharma Professionals Reveals Tariffs Increased Production Costs and Disrupted Supply Chains

对90名生物制药专业人士的调查显示，关税增加了生产成本并扰乱了供应链。

Menopause Linked to Structural Changes in Brain Regions Governing Memory and Emotional Processing

更年期与控制记忆和情绪处理的大脑区域的结构变化有关

Researchers Identify Adaptive Genetic Variants in Indian Yak Populations Using ddRAD Sequencing

研究人员使用ddRAD测序鉴定印度牦牛群体中的适应性遗传变异

©www.geneonline.com All rights reserved. Collaborate with us:

©www.geneonline.com 版权所有。与我们合作：

[email protected]

电子邮件地址

Author

作者

GOAI

GOAI

Related Post

相关文章

News Flash

新闻快讯

Alphamab Develops Bispecific Antibody-Drug Conjugates with Lower Antibody-Drug Ratios to Enhance Cancer Treatment

康宁杰瑞开发低抗体药物比率的双特异性抗体药物偶联物以增强癌症治疗效果

2025-12-19

2025年12月19日